Selected research
Market Structure
Global Pharmacodynamic Biomarker Assay Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmacodynamic Biomarker Assay market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharmacodynamic Biomarker Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmacodynamic Biomarker Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmacodynamic Biomarker Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmacodynamic Biomarker Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmacodynamic Biomarker Assay include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott and Agilent Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharmacodynamic Biomarker Assay market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmacodynamic Biomarker Assay and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmacodynamic Biomarker Assay revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacodynamic Biomarker Assay market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmacodynamic Biomarker Assay Segment by Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Pharmacodynamic Biomarker Assay Segment by Type
Exposure Biomarkers
Effect Biomarkers
Susceptibility Biomarkers
Pharmacodynamic Biomarker Assay Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
Pharmacodynamic Biomarker Assay Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacodynamic Biomarker Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacodynamic Biomarker Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacodynamic Biomarker Assay.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacodynamic Biomarker Assay in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacodynamic Biomarker Assay industry.
Chapter 3: Detailed analysis of Pharmacodynamic Biomarker Assay companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacodynamic Biomarker Assayrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Exposure Biomarkers
- Effect Biomarkers
- Susceptibility Biomarkers
Applications
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Others
Companies covered
- Thermo Fisher Scientific
- Merck
- Bio-Rad Laboratories
- QIAGEN
- Roche
- Danaher Corporation
- Siemens Healthcare
- Abbott
- Agilent Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmacodynamic Biomarker Assay Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Exposure Biomarkers
- 1.2.3 Effect Biomarkers
- 1.2.4 Susceptibility Biomarkers
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharmacodynamic Biomarker Assay Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Diagnostics
- 1.3.3 Drug Discovery
- 1.3.4 Personalized Medicine
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharmacodynamic Biomarker Assay Growth Trends by Region
- 1.5.1 Global Pharmacodynamic Biomarker Assay Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharmacodynamic Biomarker Assay Market Size by Region (2021-2026)
- 1.5.3 Pharmacodynamic Biomarker Assay Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharmacodynamic Biomarker Assay Market Dynamics
- 2.1 Pharmacodynamic Biomarker Assay Industry Trends
- 2.2 Pharmacodynamic Biomarker Assay Industry Drivers
- 2.3 Pharmacodynamic Biomarker Assay Industry Opportunities and Challenges
- 2.4 Pharmacodynamic Biomarker Assay Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharmacodynamic Biomarker Assay Revenue by Company (2021-2026)
- 3.2 Global Pharmacodynamic Biomarker Assay Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharmacodynamic Biomarker Assay Key Company Head office and Area Served
- 3.4 Global Pharmacodynamic Biomarker Assay Company, Product Type & Application
- 3.5 Global Pharmacodynamic Biomarker Assay Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharmacodynamic Biomarker Assay Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharmacodynamic Biomarker Assay Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharmacodynamic Biomarker Assay Tier 1, Tier 2, and Tier 3
4 Pharmacodynamic Biomarker Assay Market by Type
- 4.1 Global Pharmacodynamic Biomarker Assay Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharmacodynamic Biomarker Assay Market Size by Type (2021-2032)
- 4.3 Global Pharmacodynamic Biomarker Assay Market Size Share by Type (2021-2032)
5 Pharmacodynamic Biomarker Assay Market by Application
- 5.1 Global Pharmacodynamic Biomarker Assay Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharmacodynamic Biomarker Assay Market Size by Application (2021-2032)
- 5.3 Global Pharmacodynamic Biomarker Assay Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher Scientific Pharmacodynamic Biomarker Assay Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Merck Pharmacodynamic Biomarker Assay Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Bio-Rad Laboratories
- 6.3.1 Bio-Rad Laboratories Company Information
- 6.3.2 Bio-Rad Laboratories Business Overview
- 6.3.3 Bio-Rad Laboratories Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Bio-Rad Laboratories Pharmacodynamic Biomarker Assay Product Portfolio
- 6.3.5 Bio-Rad Laboratories Recent Developments
- 6.4 QIAGEN
- 6.4.1 QIAGEN Company Information
- 6.4.2 QIAGEN Business Overview
- 6.4.3 QIAGEN Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 QIAGEN Pharmacodynamic Biomarker Assay Product Portfolio
- 6.4.5 QIAGEN Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Roche Pharmacodynamic Biomarker Assay Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 Danaher Corporation
- 6.6.1 Danaher Corporation Company Information
- 6.6.2 Danaher Corporation Business Overview
- 6.6.3 Danaher Corporation Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Danaher Corporation Pharmacodynamic Biomarker Assay Product Portfolio
- 6.6.5 Danaher Corporation Recent Developments
- 6.7 Siemens Healthcare
- 6.7.1 Siemens Healthcare Company Information
- 6.7.2 Siemens Healthcare Business Overview
- 6.7.3 Siemens Healthcare Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Siemens Healthcare Pharmacodynamic Biomarker Assay Product Portfolio
- 6.7.5 Siemens Healthcare Recent Developments
- 6.8 Abbott
- 6.8.1 Abbott Company Information
- 6.8.2 Abbott Business Overview
- 6.8.3 Abbott Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Abbott Pharmacodynamic Biomarker Assay Product Portfolio
- 6.8.5 Abbott Recent Developments
- 6.9 Agilent Technologies
- 6.9.1 Agilent Technologies Company Information
- 6.9.2 Agilent Technologies Business Overview
- 6.9.3 Agilent Technologies Pharmacodynamic Biomarker Assay Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Agilent Technologies Pharmacodynamic Biomarker Assay Product Portfolio
- 6.9.5 Agilent Technologies Recent Developments
7 North America
- 7.1 North America Pharmacodynamic Biomarker Assay Market Size (2021-2032)
- 7.2 North America Pharmacodynamic Biomarker Assay Market Size by Type
- 7.2.1 North America Pharmacodynamic Biomarker Assay Market Size by Type (2021-2026)
- 7.2.2 North America Pharmacodynamic Biomarker Assay Market Size by Type (2027-2032)
- 7.2.3 North America Pharmacodynamic Biomarker Assay Market Share by Type (2021-2032)
- 7.3 North America Pharmacodynamic Biomarker Assay Market Size by Application
- 7.3.1 North America Pharmacodynamic Biomarker Assay Market Size by Application (2021-2026)
- 7.3.2 North America Pharmacodynamic Biomarker Assay Market Size by Application (2027-2032)
- 7.3.3 North America Pharmacodynamic Biomarker Assay Market Share by Application (2021-2032)
- 7.4 North America Pharmacodynamic Biomarker Assay Market Size by Country
- 7.4.1 North America Pharmacodynamic Biomarker Assay Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharmacodynamic Biomarker Assay Market Size by Country (2021-2026)
- 7.4.3 North America Pharmacodynamic Biomarker Assay Market Size by Country (2027-2032)
- 7.4.4 North America Pharmacodynamic Biomarker Assay Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharmacodynamic Biomarker Assay Market Size (2021-2032)
- 8.2 Europe Pharmacodynamic Biomarker Assay Market Size by Type
- 8.2.1 Europe Pharmacodynamic Biomarker Assay Market Size by Type (2021-2026)
- 8.2.2 Europe Pharmacodynamic Biomarker Assay Market Size by Type (2027-2032)
- 8.2.3 Europe Pharmacodynamic Biomarker Assay Market Share by Type (2021-2032)
- 8.3 Europe Pharmacodynamic Biomarker Assay Market Size by Application
- 8.3.1 Europe Pharmacodynamic Biomarker Assay Market Size by Application (2021-2026)
- 8.3.2 Europe Pharmacodynamic Biomarker Assay Market Size by Application (2027-2032)
- 8.3.3 Europe Pharmacodynamic Biomarker Assay Market Share by Application (2021-2032)
- 8.4 Europe Pharmacodynamic Biomarker Assay Market Size by Country
- 8.4.1 Europe Pharmacodynamic Biomarker Assay Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharmacodynamic Biomarker Assay Market Size by Country (2021-2026)
- 8.4.3 Europe Pharmacodynamic Biomarker Assay Market Size by Country (2027-2032)
- 8.4.4 Europe Pharmacodynamic Biomarker Assay Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharmacodynamic Biomarker Assay Market Size (2021-2032)
- 9.2 China Pharmacodynamic Biomarker Assay Market Size by Type
- 9.2.1 China Pharmacodynamic Biomarker Assay Market Size by Type (2021-2026)
- 9.2.2 China Pharmacodynamic Biomarker Assay Market Size by Type (2027-2032)
- 9.2.3 China Pharmacodynamic Biomarker Assay Market Share by Type (2021-2032)
- 9.3 China Pharmacodynamic Biomarker Assay Market Size by Application
- 9.3.1 China Pharmacodynamic Biomarker Assay Market Size by Application (2021-2026)
- 9.3.2 China Pharmacodynamic Biomarker Assay Market Size by Application (2027-2032)
- 9.3.3 China Pharmacodynamic Biomarker Assay Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharmacodynamic Biomarker Assay Market Size (2021-2032)
- 10.2 Asia Pharmacodynamic Biomarker Assay Market Size by Type
- 10.2.1 Asia Pharmacodynamic Biomarker Assay Market Size by Type (2021-2026)
- 10.2.2 Asia Pharmacodynamic Biomarker Assay Market Size by Type (2027-2032)
- 10.2.3 Asia Pharmacodynamic Biomarker Assay Market Share by Type (2021-2032)
- 10.3 Asia Pharmacodynamic Biomarker Assay Market Size by Application
- 10.3.1 Asia Pharmacodynamic Biomarker Assay Market Size by Application (2021-2026)
- 10.3.2 Asia Pharmacodynamic Biomarker Assay Market Size by Application (2027-2032)
- 10.3.3 Asia Pharmacodynamic Biomarker Assay Market Share by Application (2021-2032)
- 10.4 Asia Pharmacodynamic Biomarker Assay Market Size by Country
- 10.4.1 Asia Pharmacodynamic Biomarker Assay Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharmacodynamic Biomarker Assay Market Size by Country (2021-2026)
- 10.4.3 Asia Pharmacodynamic Biomarker Assay Market Size by Country (2027-2032)
- 10.4.4 Asia Pharmacodynamic Biomarker Assay Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharmacodynamic Biomarker Assay Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst